Portfolio Update

RNS Number : 5498E

Intl. Biotechnology Trust PLC

22 December 2009

 



INTERNATIONAL BIOTECHNOLOGY TRUST PLC    

Portfolio update as at 30 November 2009                    

Total Net Assets	£95.6m
NAV per share	149.0p
Share Price	120.5p
Total value of unquoted investments	£20.3m
Total number of portfolio companies	57
Cash	6%
Cash committed and reserved to unquoted investments	13%
Portfolio companies with < 1 year of cash	1%

Top Ten Holdings

Company Name	% NAV	Market Value
Micromet	10.19	9,740,487
Celgene	6.62	6,327,835
Amgen	5.72	5,468,089
Gilead Sciences	4.53	4,334,850
Prime Rate Sterling Liquidity Class 3	3.66	3,502,037
Genzyme	3.48	3,329,128
Alexion Pharmaceuticals	3.42	3,271,056
Wright Medical	3.03	2,896,836
HSBC Sterling Liquid Fund B shares	2.41	2,300,645
Vertex Pharmaceuticals	2.38	2,275,939
	-----------	--------------
Total	45.44	43,446,902

Geographical Allocation	%
United States	78
Europe	14
Cash	6
Australia	2
	-----------
Total	100

Quoted/Unquoted allocation	%
Quoted	73
Unquoted	21
Cash	6
	-----------
	100

BNP Paribas Secretarial Services Limited

Company Secretary

22 DECEMBER 2009

 

END

 

 

PFUBBBDDLXDGGCD